Marcial Delgado

812 total citations
9 papers, 522 citations indexed

About

Marcial Delgado is a scholar working on Hepatology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Marcial Delgado has authored 9 papers receiving a total of 522 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hepatology, 5 papers in Infectious Diseases and 3 papers in Epidemiology. Recurrent topics in Marcial Delgado's work include Hepatitis C virus research (5 papers), HIV/AIDS drug development and treatment (5 papers) and Liver Disease Diagnosis and Treatment (3 papers). Marcial Delgado is often cited by papers focused on Hepatitis C virus research (5 papers), HIV/AIDS drug development and treatment (5 papers) and Liver Disease Diagnosis and Treatment (3 papers). Marcial Delgado collaborates with scholars based in Spain, Switzerland and Austria. Marcial Delgado's co-authors include J.M. Reguera, Francisco Martos, C. Juárez, Jordi Colmenero, Juan A. Pineda, Antonio Rivero, J.F. Castroagudı́n, Santiago Tomé, Juan Macı́as and Evaristo Varó and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Scientific Reports.

In The Last Decade

Marcial Delgado

8 papers receiving 489 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marcial Delgado Spain 6 427 336 116 75 74 9 522
Paloma Geijo Spain 12 308 0.7× 338 1.0× 77 0.7× 46 0.6× 38 0.5× 20 566
Ali İrfan Baran Türkiye 7 461 1.1× 355 1.1× 162 1.4× 76 1.0× 64 0.9× 27 624
Hanefi Cem Gül Türkiye 9 185 0.4× 206 0.6× 35 0.3× 69 0.9× 58 0.8× 39 337
Mehmet Uluğ Türkiye 11 94 0.2× 124 0.4× 45 0.4× 26 0.3× 12 0.2× 39 313
Ergin Ayaşlıoğlu Türkiye 10 111 0.3× 117 0.3× 58 0.5× 19 0.3× 51 0.7× 25 319
Reşit Mıstık Türkiye 9 65 0.2× 210 0.6× 14 0.1× 29 0.4× 44 0.6× 33 345
M. I. Khateeb Kuwait 7 418 1.0× 242 0.7× 106 0.9× 71 0.9× 112 1.5× 9 448
Paşa Göktaş Türkiye 13 92 0.2× 210 0.6× 28 0.2× 53 0.7× 28 0.4× 26 419
Abdul Razzak Al Yusuf Kuwait 7 187 0.4× 151 0.4× 67 0.6× 30 0.4× 38 0.5× 8 316
Juan Diego Ruíz-Mesa Spain 8 188 0.4× 198 0.6× 70 0.6× 27 0.4× 27 0.4× 10 458

Countries citing papers authored by Marcial Delgado

Since Specialization
Citations

This map shows the geographic impact of Marcial Delgado's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcial Delgado with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcial Delgado more than expected).

Fields of papers citing papers by Marcial Delgado

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcial Delgado. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcial Delgado. The network helps show where Marcial Delgado may publish in the future.

Co-authorship network of co-authors of Marcial Delgado

This figure shows the co-authorship network connecting the top 25 collaborators of Marcial Delgado. A scholar is included among the top collaborators of Marcial Delgado based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcial Delgado. Marcial Delgado is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Gómez‐Ayerbe, Cristina, Rosario Palacios, Dolores Merino, et al.. (2022). Weight changes after first-line antiretroviral initiation in a cohort of HIV-positive patients in Southern Spain (CAPOTA study). International Journal of STD & AIDS. 33(13). 1119–1123. 2 indexed citations
2.
Real, Luís Miguel, Juan Macı́as, Ana Belén Pérez, et al.. (2018). Baseline resistance-guided therapy does not enhance the response to interferon-free treatment of HCV infection in real life. Scientific Reports. 8(1). 14905–14905. 3 indexed citations
3.
Neukam, Karin, Daniela Munteanu, Antonio Rivero‐Juárez, et al.. (2015). Boceprevir or Telaprevir Based Triple Therapy against Chronic Hepatitis C in HIV Coinfection: Real-Life Safety and Efficacy. PLoS ONE. 10(4). e0125080–e0125080. 9 indexed citations
4.
Viciana, Isabel, Carmen María González-Domenech, Rosario Palacios, et al.. (2015). Clinical, virological and phylogenetic characterization of a multiresistant HIV-1 strain outbreak in naive patients in southern Spain. Journal of Antimicrobial Chemotherapy. 71(2). 357–361. 5 indexed citations
5.
Macı́as, Juan, Luís F. López‐Cortés, Francisco Téllez, et al.. (2015). Low Efficacy of Pegylated Interferon plus Ribavirin plus Nitazoxanide for HCV Genotype 4 and HIV Coinfection. PLoS ONE. 10(12). e0143492–e0143492.
6.
Macı́as, Juan, Karin Neukam, Joaquín Portilla, et al.. (2011). Liver tolerance of raltegravir-containing antiretroviral therapy in HIV-infected patients with chronic hepatitis C. Journal of Antimicrobial Chemotherapy. 66(6). 1346–1350. 13 indexed citations
7.
Mira, José Antonio López, Alicia Gutiérrez‐Valencia, Ignacio de los Santos, et al.. (2009). Efficacy and Safety of Pegylated Interferon plus Ribavirin in HIV and Hepatitis C Virus–Coinfected Patients with Advanced Immunosuppression. Clinical Infectious Diseases. 49(8). e84–e91. 14 indexed citations
8.
Varó, Evaristo, E. Otero, Santiago Tomé, et al.. (2002). Cardiovascular risk factors in liver allograft recipients: relationship with immunosuppressive therapy. Transplantation Proceedings. 34(5). 1553–1554. 15 indexed citations
9.
Colmenero, Jordi, et al.. (1996). Complications Associated with Brucella melitensis Infection: A Study of 530 Cases. Medicine. 75(4). 195–211. 461 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026